Efficacy of Clomiphene Citrate and Letrozole in Induction of Ovulation in Patients of PCOS: A Randomized Prospective Clinical Trial
Ovulatory dysfunction is an important cause of infer-tility and PCO remains one of its leading causes. Clo-miphene citrate has been traditionally used as the drug of choice in treating women with an ovulatory infer-tility. In the last decade letrozole, an aromatase inhibi-tor has emerged as an alternate ovulation inducing agent.
Objectives: The purpose of this study was to compare the efficacy of letrozole with clomiphene citrate. The primary outcome measure was the occurrence of ovu-lation, mature follicles and endometrial thickness. Al-though measuring pregnancy rate was not our main objective but we found that pregnancy outcome was better in the letrozole group than the clomiphene gro-up.Methodology: In this prospective randomized clinical trial 140 women with Polycystic ovarian disease in the WHO group II were randomized to receive either letrozole or clomiphene citrate. Patients were rando-mly divided into two groups by lottery and treated with 2.5 mg / day or 150 mg / day for 5 days starting from day 3 of menstruation. Data was managed using SPSS version 17.
Results: The mean age of the patients was 26.3 ± 4.1 years old (range, 22 – 35) and the mean duration of infertility was 3.66 ± 1.9 years (range, 1 – 9). The mean endometrial thickness in letrozole group was 10.42 ± 0.487 mm and in clomiphene citrate the mean endometrial thickness was 8.11 ± 6.2. The number of mature follicles although lower in letrozole but single leading follicle size > 18 mm were more in group A than group B, p-value < 0.05. The secondary outcome i.e. pregnancy rate was greater in letrozole group,
i.e. 36 (51.4%) as compared to clomiphene i.e. 22 (31.4%), p-value < 0.05.
Conclusion: Letrozole although it induces fewer ovulatory follicles but endometrial thickness at the time of implantation and pregnancy rate is greater than clomiphene citrate.
Keywords: Ovulation induction, endometrial thickness, letrozole, Clomiphene citrate.
How to Cite
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments firstname.lastname@example.org